Autoimmune Lymphoproliferative Syndrome Panel
New York
Approved
Genes
Conditions
- Autoimmune Lymphoproliferative Syndrome (ALPS) Type 1A
- Autoimmune Lymphoproliferative Syndrome Type IIA (ALPS IIA)
- Autoimmune Lymphoproliferative Syndrome Type IIB (ALPS IIB)
Clinical Utility
- Confirmation of the clinical diagnosis.
- Differentiation from malignant forms of lymphoproliferation.
- Distinguish sub-type of ALPS.
- Development of an appropriate treatment plan for affected individuals.
- Development of an appropriate medical surveillance plan for relatives at risk of lymphoma.
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
T990
CPT Codes*
81479x1
ABN Required
No
Turnaround Time**
3 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing